Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
African Journal of Laboratory Medicine|January 21, 2020
Resazurin microtitre plate assay and Sensititre® MycoTB for detection of <i>Mycobacterium tuberculosis</i> resistance in a high tuberculosis resistance settingPrenika Jaglal, Melendhran Pillay, Koleka MlisanaPlos One|November 14, 2013
Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV regionYacoob Mahomed Coovadia, Sharana Mahomed, Melendhran Pillay, et al.Viruses|July 2, 2021
HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing TechnologiesSontaga Manyana, Lilishia Gounder, Melendhran Pillay, et al.AIDS Research and Therapy|February 10, 2023
Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settingsSontaga Manyana, Melendhran Pillay, Lilishia Gounder, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|June 1, 2021
<i>In vitro</i> anti-TB properties, <i>in silico</i> target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against <i>Mycobacterium tuberculosis</i>Pran Kishore Deb, Nizar A Al-Shar'i, Katharigatta N Venugopala, et al.Oral Oncology|February 3, 2025
Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?Aabida Khan, Melendhran Pillay, Rishan Bipath, et al.Chemical Biology & Drug Design|November 16, 2012
Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chloridesVenugopala K Narayanaswamy, Susanta K Nayak, Melendhran Pillay, et al.AIDS Research and Human Retroviruses|October 31, 2019
Short Communication: Early Antiretroviral Therapy Is Associated with Better Viral Suppression and Less HIV Drug Resistance After Implementation of Universal Treatment in South AfricaJienchi Dorward, Paul K Drain, Farzana Osman, et al.European Journal of Medicinal Chemistry|June 5, 2012
Novel polycyclic 'cage'-1,2-diamines as potential anti-tuberculosis agentsOluseye K Onajole, Yacoob Coovadia, Hendrik G Kruger, et al.Open Forum Infectious Diseases|April 27, 2019
<i>rpoB</i> Mutations Causing Discordant Rifampicin Susceptibility in <i>Mycobacterium tuberculosis</i>: Retrospective Analysis of Prevalence, Phenotypic, Genotypic, and Treatment OutcomesNomonde R Mvelase, Melendhran Pillay, Wilbert Sibanda, et al.Pageof 4